FFA
MRNA icon

Frazier Financial Advisors’s Moderna MRNA Stock Holding History

Frazier Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5K Hold
636
– – 0.02% 199
2026
Q1 		$32.3K Hold
636
– – 0.02% 242
2025
Q4 		$18.8K Hold
636
– – 0.01% 283
2025
Q3 		$16.4K Hold
636
– – 0.01% 290
2025
Q2 		$17.5K Sell
636
-3
-0.5% -$79 0.01% 277
2025
Q1 		$18.1K Buy
639
+416
+187% +$14.8K 0.01% 258
2024
Q4 		$8.78K Hold
223
– – 0.01% 367
2024
Q3 		$14.9K Hold
223
– – 0.01% 299
2024
Q2 		$26.5K Hold
223
– – 0.02% 240
2024
Q1 		$23.8K Buy
223
+3
+1% +$302 0.02% 236
2023
Q4 		$21.9K Buy
+220
New +$18.5K 0.02% 225

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Frazier Financial Advisors's MRNA Position: Q2 2026 in Review

Frazier Financial Advisors held its Moderna (MRNA) position steady in Q2 2026 at 636 shares worth $44.5K. The position accounts for 0.02% of the portfolio, ranked #199.

Frazier Financial Advisors first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Frazier Financial Advisors held 636 shares of Moderna worth $44.5K as of Q2 2026.
  • Frazier Financial Advisors left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.02% of Frazier Financial Advisors's portfolio in Q2 2026, its #199 holding.
  • Frazier Financial Advisors first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.